Durmaz, BDurmaz, RSahin, K2024-08-042024-08-0419970195-67011532-2939https://doi.org/10.1016/S0195-6701(97)90149-3https://hdl.handle.net/11616/930951st European Congress of Chemotherapy -- MAY 13-17, 1996 -- GLASGOW, SCOTLANDThe purposes of this study were to determine the prevalence of Turkish isolates of methicillin-resistant Staphylococcus aureus (MRSA) in nosocomial and community infections and their antibiotic resistant patterns. The oxacillin disk diffusion method for the detection of methicillin resistance and the Kirby-Bauer disk diffusion for antibiotic susceptibility tests were used. A total 383 S. aureus strains were identified from different patients. The prevalence of methicillin resistance among S. aureus strains was 31.3% (120/383). The proportions of MRSA isolated from nosocomial and community infections were 26.4% (46/174) and 35.4% (74/209), respectively. The resistance rates of MRSA to other antibiotics were as follows: 71% resistant to erythromycin, 54% to clindamycin, 52% to gentamicin, 44.5% to trimethoprim-sulfamethoxazole and 36% to ciprofloxacin. No strain resistant to vancomycin was recorded in this study.eninfo:eu-repo/semantics/closedAccessMRSAnosocomialcommunityinfectionConference Object374325329945761010.1016/S0195-6701(97)90149-32-s2.0-0031456440Q1WOS:000072891800008Q2